Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Surfactant administered via Laryngeal Mask Airway (LMA)
standard of care (nasal CPAP and supplemental oxygen)
Locations
1
United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
June 1, 2005
Primary Completion Date
June 1, 2009
Completion Date
December 1, 2009
Last Updated
May 7, 2010
NCT06007547
NCT05260424
NCT06606444
NCT07009366
NCT00244101
NCT02294630
Lead Sponsor
University of Virginia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions